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Abstract
Aims/hypothesis A history of gastric bypass surgery can
influence the results of the OGTT recommended during
pregnancy. Therefore, we compared OGTT glucose kinetics
and pregnancy outcome between pregnant gastric bypass
patients and BMI-matched, lean and obese controls.
Methods Medical records were used to collect data on glucose
measurements during the 2 h 75 g OGTT as well as on
pregnancy and fetal outcome for 304 women (n= 76 per
group, matched for age and date of delivery).
Results Women after bariatric surgery had lower fasting
glucose levels compared with lean, obese and BMI-matched
controls, and showed altered postprandial glucose kinetics,
including a rise at 60 min followed by hypoglycaemia with
serum glucose of <3.34 mmol/l (which occurred in 54.8%).
Moreover, their risk of pre-eclampsia or gestational
hypertension was reduced, with an increased risk of delivering
small for gestational age infants.
Conclusions/interpretation Alternative strategies to accurately
define impaired glucose metabolism in pregnancies after
bariatric surgery should be explored.
Keywords Bariatric surgery . Hypoglycaemia . OGTT .
Pre-eclampsia . Pregnancy
Abbreviations
GDM Gestational diabetes mellitus
IADPSG International Association of Diabetes in
Pregnancy Study Groups
LGA Large for gestational age
SGA Small for gestational age
Introduction
The International Association of Diabetes in Pregnancy Study
Groups (IADPSG) 2010 criteria proposed performing an
OGTT between the 24th and 28th week of gestation as the
gold standard to diagnose gestational diabetes mellitus
(GDM) [1]. After adoption of these criteria by other health-
care organisations, some countries (e.g. Austria) implemented
the OGTT as a mandatory examination in pregnancy.
However, there might be populations in which this screening
strategy is less effective or even harmful.
Nowadays, owing to theworldwide rising obesity prevalence,
malabsorptive surgery (such as Roux-en-Y gastric bypass) is an
emerging treatment that has beneficial effects on glucose
metabolism [2]. As gastric bypass surgery is associated with an
altered rise in the levels of nutrients (especially glucose), it can
potentially influence the results of the OGTT and therefore the
transferability of diagnostic guidelines [3]. To our knowledge,
the extent of altered glucose kinetics in pregnancies following
bariatric surgery and its specific impact on GDM diagnosis, as
well as effects on the growing fetus, have not been thoroughly
investigated until now.
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Study participants This retrospective cohort study included a
total of 304 women who attended our pregnancy out-patient
clinic between January 2007 and January 2016: 76 after
gastric bypass surgery (i.e. all pregnant women for whom a
history of gastric bypass surgery was reported in this period),
76 with preconceptional obesity (preconceptional BMI
≥30 kg/m2), 76 normal weight (preconceptional BMI
18–25 kg/m2) and 76 BMI-matched controls. The groups
were additionally matched for maternal age and date of
delivery. Medical records were used to collect data on
maternal variables including results of the routinely performed
2 h 75 g OGTTexamination (that measures fasting and 60min
and 120 min post-load glucose levels), as well as pregnancy
outcome and infant bodymeasures at delivery. Calculations of
age- and sex-adjusted percentiles of the Austrian population
were based on an analysis of the local growth standard curves.
Large for gestational age (LGA) and small for gestational age
(SGA) were defined as a bodyweight above the 90th
percentile or below the 10th percentile, respectively. The
study was approved by the local ethics committee.
Statistical analysis Continuous and categorical variables
were summarised as means ±SD (or medians [interquartile
range]) and counts and percentages, respectively. Multiple
comparisons (gastric bypass vs all other subgroups) were
performed by ANOVA and Dunnett post hoc tests (for
continuous variables) or Fisher’s exact test followed by the
Bonferroni–Holm correction (for categorical variables) to
achieve a 95% coverage probability.
Statistical analysis was performed with R (version 3.2.4,
R Foundation for Statistical Computing, Vienna, Austria) and
add-ons (multcomp, beeswarm and lattice). The two-sided
significance level was set to 0.05.
Results
A description of the study population is provided in Table 1.
While maternal age and parity were comparable among
groups, we observed characteristic plasma glucose kinetics
profiles during the OGTT. In particular, patients after bariatric
surgery, who started with the lowest plasma glucose at fasting,
showed a significant increase at 60 min following an oral
glucose load. However, at 120 min after ingestion, glucose
concentrations tended to decrease to below baseline levels in
this subgroup. Postprandial hypoglycaemia (defined as a
plasma glucose level of <3.34 mmol/l) was observed in
54.8% of pregnant women after gastric bypass surgery.
Therefore, postprandial glucose kinetics in these patients were
strikingly divergent compared with normal weight,
BMI-matched and obese women; the latter group of obese
women had no hypoglycaemic episodes but the highest risk
of fasting and postprandial hyperglycaemia (Fig. 1).
Accordingly, a diagnosis of GDM based on the IADPSG
criteria was most commonly observed after 60 min in gastric
bypass patients. When only fasting or 120 min glucose levels
were considered, gastric bypass patients had a significantly
lower incidence of GDM compared with obese and
weight-matched controls. Postprandial hypoglycaemia at
120 min occurred in 39.3% of women with gastric bypass
surgery, who exceeded the IADPSG thresholds at 60 min.
While the risk of pregnancy-induced hypertension or
pre-eclampsia was lowest in patients with a history of gastric
bypass surgery, no group-specific differences were found for
obstetric outcome such as induction of labour, gestational age
at delivery, or need of Caesarean section or neonatal intensive
care. Of note, newborn infants of gastric bypass patients
tended to be smaller with the highest risk of being SGA
(electronic supplementary material Fig. 1). Maternal GDM
status was not associated with increased birthweight
percentiles (p = 0.901). Consequently, our conclusions
remained the same after adjusting for GDM in multivariable
analysis. Moreover, no interaction between a history of
bariatric surgery and GDM status was found. Correlation
analyses revealed that birthweight tended to be positively
associated with fasting plasma glucose in women after gastric
bypass (Spearman’s ρ=0.29, p=0.036), whereas this association
was not observed forOGTT levels at 60min or 120min.Maternal
hypoglycaemia at 120 min was not related to the risk of SGA
offspring; however, the limited sample size has to be considered
when drawing conclusions based on this finding.
Discussion
Our results indicate altered glucose kinetics profiles during an
OGTT, including a distinctive rise in plasma glucose levels at
60 min followed by hypoglycaemic episodes, in more than a
half of pregnant patients with history of gastric bypass
surgery. Moreover, the risk of pre-eclampsia or gestational
hypertensionwas found to be reduced (gastric bypass vs obese
mothers), whereas the newborn infants of mothers with a
history of gastric bypass had a lower birthweight and were at
a higher risk of being SGA compared with those of obese and
normal weight controls. The differences in glucose kinetics
and neonatal outcome appear to be independent of BMI
because differences were also seen with BMI-matched patients.
The pathophysiological mechanisms leading to
hypoglycaemia in gastric bypass patients are not fully
understood. Although reports of OGTT data during pregnancy
are sparse, studies in non-pregnant women suggest that
altered gastric glucose transit followed by increased incretin
peptide release and exaggerated insulin secretion from pancre-
atic beta cells, might provide an explanation [4]. Although we
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cannot provide further insight into these pathophysiological
issues owing to our retrospective study design, these results
have raised some important questions about screening and the
definition of GDM. Recently, Johansson et al provided
detailed information on pregnancy outcomes after bariatric
surgery, including a lower risk of GDM (1.9% vs 6.8%) and
LGA infants, although the risk of SGA was increased [5].
However, one criticism is that the use of routinely performed
2 h OGTT examinations in some previous studies might be
considered inappropriate to detect hyperglycaemia [6]. Using
the IADPSG definition, we observed a markedly increased
incidence of GDM in bariatric surgery patients with glucose
excursions, particularly those occurring at 60 min. While the
clinical implication of this observation has not been
established, it should be kept in mind that the GDM incidence
was lowest in gastric bypass patients when fasting glucose and
120 min glucose levels (and not 60 min glucose levels) were
used to classify hyperglycaemia in this subgroup. In addition,
women with a history of gastric bypass showed lower fasting
glucose levels, indicating some glycaemic improvement
Table 1 Characteristics of the study population
Maternal/fetal characteristic GBS NW BMIM OB
n Value n Value n Value n Value
Age, years 76 31.6 ± 6.3 76 31.5 ± 6.1 76 31.5 ± 5.5 76 31.6 ± 5.7
BMI, kg/m2 74 30.4 ± 5.9 76 21.8 ± 1.7* 76 30.0 ± 5.9 76 35.0 ± 4.3*
FG, mmol/l 62 4.16± 0.37 76 4.45± 0.57* 76 4.69 ± 0.52* 74 4.94 ± 0.63*
FG≥ 5.1 mmol/l 62 0 (0.0) 76 5 (6.6)* 76 17 (22.4)* 74 26 (35.1)*
G-60, mmol/l 62 9.46± 2.41 76 7.42± 2.12* 76 8.16 ± 1.78* 74 8.93 ± 2.04
ΔG-60 (vs FG), mmol/l 62 5.30± 2.38 76 2.96± 1.95* 76 3.47 ± 1.79* 74 3.99 ± 1.78*
G-60≥ 10.0 mmol/l 62 27 (43.5) 76 10 (13.2)* 76 13 (17.1)* 74 27 (36.5)
G-120, mmol/l 62 3.72± 1.60 76 5.62± 1.41* 76 6.18 ± 1.68* 74 6.93 ± 1.79*
ΔG-120 (vs FG), mmol/l 62 −0.44± 1.55 76 1.16± 1.31* 76 1.49 ± 1.75* 74 2.00 ± 1.61*
G-120 ≥ 8.5 mmol/l 62 1 (1.6) 76 4 (5.3) 76 10 (13.2)* 74 14 (18.9)*
G-120 < 3.34 mmol/l 62 34 (54.8) 76 3 (3.9)* 76 1 (1.3)* 74 0 (0.0)*
GDMb (overall) 62 28 (45.2) 76 12 (15.8)* 76 31 (40.8) 74 39 (52.7)
GDMb (FG or G-60) 62 27 (43.5) 76 11 (14.5)* 76 27 (35.5) 74 38 (51.4)
GDMb (FG or G-120) 62 1 ( 1.6) 76 7 (9.2) 76 26 (34.2)* 74 34 (45.9)*
Insulin treatment 76 11 (14.5) 76 7 (9.2) 76 16 (21.1) 76 19 (25.0)
Hypertension or PE 72 1 (1.4) 76 5 (6.6) 76 6 (7.9) 76 11 (14.5)*
Parity 76 2 (1–3) 76 2 (1–2) 76 2 (1–2.25) 76 2 (1–3)
Reproductive medicine 76 5 (6.6) 76 7 (9.2) 76 4 (5.3) 76 5 (6.6)
Multiple pregnancy 76 7 (9.2) 76 8 (10.5) 76 13 (17.1) 76 8 (10.5)
Lung maturity inductiona 65 12 (18.5) 68 4 (5.9) 63 3 (4.8) 68 8 (11.8)
Induction of laboura 65 6 (9.2) 68 10 (14.7) 63 7 (11.1) 68 8 (11.8)
Caesarean sectiona 64 31 (48.4) 68 25 (36.8) 63 43 (68.3) 68 39 (57.4)
Neonatal intensive carea 64 7 (10.9) 68 5 (7.4) 63 5 (7.9) 68 5 (7.4)
GADa, weeks 64 39 (38–40) 68 40 (39–40) 63 39 (38–39) 68 39 (38–40)
Birthweighta, percentile 64 32.7 ± 26.3 68 44.7 ± 29.7* 63 51.7 ± 27.5* 66 52.2 ± 28.2*
Birth lengtha, percentile 62 37.2 ± 27.9 66 47.3 ± 28.1 61 51.3 ± 27.8* 66 44.3 ± 28.0
Heada, percentile 62 38.4 ± 26.3 68 39.0 ± 26.5 59 50.6 ± 30.2* 61 52.4 ± 28.4*
SGAa 64 18 (28.1) 68 11 (16.2) 63 7 (11.1)* 66 7 (10.6)*
LGAa 64 1 (1.6) 68 7 (10.3) 63 5 (7.9) 66 7 (10.6)
Data are n, means ± SD or medians (interquartile range) for continuous variables, and n (%) for categorical variables
a Excluding data for multiple pregnancies
b Based on IADPSG criteria
*p< 0.05 vs GBS
BMIM, BMI matched; FG, fasting plasma glucose level; G-60, plasma glucose level at 60 min after oral glucose load; G-120, plasma glucose level at
120 min after oral glucose load; GAD, gestational age at delivery; GBS, gastric bypass surgery patients; NW, normal weight; OB, obese controls; PE,
pre-eclampsia
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compared with obese, BMI-matched and even normal weight
controls. These factors might contribute to the lower number
of pregnant gastric bypass patients suffering from gestational
hypertension and pre-eclampsia [7]. However, the specif-
ic impact of higher glycaemic variability on the course of
pregnancy and pregnancy outcome, as well as the causes
of the high incidence of SGA offspring, requires further
investigation.
An unresolved question is how pregnancy-related
hyperglycaemia should be screened in the growing population
of gastric bypass women. Fasting glucose examination might
serve as an acceptable marker to rule out GDM. Its lack in
sensitivity might be improved by additionally including data
on the patients’ medical history and sociodemographic
variables [8]. Moreover, frequent capillary blood glucose
examinations [9] or even continuous subcutaneous glucose
monitoring [10] might represent diagnostic alternatives.
These methods have the major advantage of detecting
postprandial hyper- or hypoglycaemic episodes in real-life
conditions (which can hardly be achieved by a single OGTT
examination).
The retrospective nature of our study is a possible
limitation because we were not able to provide information
on nutritional status and its possible impact on pregnancy
outcome or glycaemic variability. Although these issues need
to be addressed in prospective investigations (including
nutritional protocols and long-term glucose monitoring), our
study represents a first attempt to describe OGTTalterations in
pregnancies following gastric bypass surgery and has possible
implications for GDM diagnosis. One advantage is that we
could generate a large sample of OGTT glucose profiles to
compare with lean, obese and weight-matched controls.
Based on our results, we conclude that plasma glucose
concentrations after an oral glucose load are severely altered
in pregnant gastric bypass patients. As the clinical
implications of this observation are not yet clear, the diagnos-
tic accuracy of the IADPSG criteria needs to be further exam-
ined for use in prospective longitudinal studies in this group of
patients. Moreover, the potential risk of hypoglycaemia
following an oral glucose load should be considered and
alternative strategies should be discussed to rule out





























































Fig. 1 Spaghetti plots of plasma
glucose kinetics during a 2 h
OGTT in (a) pregnant patients
after gastric bypass and in (b)
normal weight, (c) BMI-matched
and (d) obese controls
156 Diabetologia (2017) 60:153–157
Acknowledgements Open access funding provided by Medical
University of Vienna.
Data availability The datasets analysed during the current study are
available from the corresponding author on request.
Funding This research received no specific grant from any funding
agency in the public, commercial or not-for-profit sectors.
Duality of interest statement The authors declare that there is no
duality of interest associated with this manuscript.
Contribution statement MF, WE, LB and CSG conceived the
study; data was assessed by MF, SS, SP, TS and SH; statistical
analysis were performed by CSG, MF and AT and data interpre-
tation was performed by CSG, MF, AT, LB, HK and AKW; CSG
and MF prepared the table and figures; and the manuscript was
written by MF and CSG and critically revised by LB, TS, HK,
AKW and AT. All authors reviewed the final draft of the manu-
script and gave final approval of the version to be published. CSG is the
guarantor of this work.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Metzger BE, Gabbe SG, Persson B et al (2010) International asso-
ciation of diabetes and pregnancy study groups recommendations
on the diagnosis and classification of hyperglycaemia in pregnancy.
Diabetes Care 33:676–682
2. Cummings DE, Arterburn DE, Westbrook EO et al (2016) Gastric
bypass surgery vs intensive lifestyle and medical intervention for
type 2 diabetes: the CROSSROADS randomised controlled trial.
Diabetologia 59:945–953
3. Dirksen C, Jorgensen NB, Bojsen-Moller KN et al (2012)
Mechanisms of improved glycaemic control after Roux-en-Y gas-
tric bypass. Diabetologia 55:1890–1901
4. Rodieux F, Giusti V, D’Alessio DA, Suter M, Tappy L (2008)
Effects of gastric bypass and gastric banding on glucose kinetics
and gut hormone release. Obesity 16:298–305
5. Johansson K, Cnattingius S, Naslund I et al (2015) Outcomes of
pregnancy after bariatric surgery. N Engl J Med 372:814–824
6. Gonzalez I, Rubio MA, Cordido F et al (2015) Maternal and peri-
natal outcomes after bariatric surgery: a Spanish multicenter study.
Obes Surg 25:436–442
7. Carpenter MW (2007) Gestational diabetes, pregnancy hypertension,
and late vascular disease. Diabetes Care 30(Suppl 2):S246–S250
8. Göbl CS, Bozkurt L, Rivic P et al (2012) A two-step screening
algorithm including fasting plasma glucose measurement and a risk
estimation model is an accurate strategy for detecting gestational
diabetes mellitus. Diabetologia 55:3173–3181
9. Allard C, Sahyouni E, Menard J et al (2015) Gestational diabetes
mellitus identification based on self-monitoring of blood glucose.
Can J Diabetes 39:162–168
10. Bonis C, Lorenzini F, Bertrand M et al (2016) Glucose profiles in
pregnant women after a gastric bypass: findings from continuous
glucose monitoring. Obes Surg 26:2150–2155
Diabetologia (2017) 60:153–157 157
